coagulation factor XII
Ultimo aggiornamento 11 Mar 2024
Rispetta le linee guida editoriali
- ScaricaScarica
- Condividi
- Language
- Discussione
- Ask Patient
- Versione audio
- Aggiungi alle fonti preferite su Google
The F12 gene provides instructions for making a protein called coagulation factor XII. Coagulation factors are a group of related proteins that are essential for normal blood clotting (coagulation). After an injury, clots protect the body by sealing off damaged blood vessels and preventing further blood loss. Factor XII circulates in the bloodstream in an inactive form until it is activated, usually by coming in contact with damaged blood vessel walls. Upon activation, factor XII interacts with coagulation factor XI. This interaction sets off a chain of additional chemical reactions that form a blood clot.
Scelte video per GenesVideo library
Normal function
The F12 gene provides instructions for making a protein called coagulation factor XII. Coagulation factors are a group of related proteins that are essential for normal blood clotting (coagulation). After an injury, clots protect the body by sealing off damaged blood vessels and preventing further blood loss. Factor XII circulates in the bloodstream in an inactive form until it is activated, usually by coming in contact with damaged blood vessel walls. Upon activation, factor XII interacts with coagulation factor XI. This interaction sets off a chain of additional chemical reactions that form a blood clot.
Factor XII also plays a role in stimulating inflammation, a normal body response to infection, irritation, or injury. When factor XII is activated, it also interacts with a protein called plasma kallikrein. This interaction initiates a series of chemical reactions that lead to the release of a protein fragment (peptide) called bradykinin. Bradykinin promotes inflammation by allowing fluids to leak through the blood vessel walls into body tissues (vascular permeability). This leakage causes the swelling that accompanies inflammation.
Conditions referring to this gene or chromosome
Altri nomi
coagulation factor XII (Hageman factor)
FA12_HUMAN
HAE3
HAEX
HAF
Hageman factor
Related patient information and medicines

Patient information leaflet
Test di coagulazione del sangue
Test di coagulazione del sangue are used to diagnose and assess bleeding problems and to monitor people who take warfarin o altro anticoagulant medicines. You may be advised to have blood clotting tests: If you h... These chemicals then react with other chemicals and proteins in the plasma, called clotting factors. There are 13 known clotting factors which.

Patient information leaflet
Pre-eclampsia
The National Institute for Health and Care Excellence (NICE) recommends that women at increased risk of developing pre-eclampsia should take low-dose aspirin. NICE recommends 75-150 mg asp... The risk of complications is reduced if pre-eclampsia is diagnosed early and treated. A rare ma serious complication is disseminated intravascular.

Patient information leaflet
Trombofilia
L clotting cascade makes the sangue solidify into a clot, which sticks to the injured part of the blood vessel. Small particles in the blood, called platelets, also help to form the clot. There are also natural chemicals in the blood which act against the clotting system, to stop the blood clotting too much. Thrombophilia occurs if the normal.

Patient information leaflet
Esofago di Barrett
The coil then emits heat energy which destroys the abnormal cells. Nearby normal cells then multiply and replace the destroyed abnormal cells. Coagulazione al plasma di argon This treatment uses a jet of argon gas, together with an electric current, to burn away dysplastic cells. Endoscopic mucosal resection (EMR) This is a procedure that is done via.

Patient information leaflet
Emorroidi
Banding treatment (rubber band ligation) Banding is the most commonly used piles treatment, especially for grade 2 and 3 piles. Coagulazione/ fotocoagulazione a infrarossi This method of piles treatment uses infrared light to burn and cut off the circulation to the haemorrhoid, which causes it to shrink in size. It may be as effective as banding.

Patient information leaflet
Anticoagulanti
In 2021, the UK's National Institute for Health and Care Excellence (NICE) recommended that DOACs should be the preferred option for AF, instead of warfarin. These activated platelets and the damaged tissue release chemicals which react with other chemicals and proteins in the blood, called clotting factors. There are 13 known clotting factors.
Ulteriori letture e riferimenti
- coagulation factor XII; MedlinePlus, National Library of Medicine.
- Bork K, Machnig T, Wulff K, Witzke G, Prusty S, Hardt J. Clinical features of genetically characterized types of hereditary angioedema with normal C1 inhibitor: a systematic review of qualitative evidence. Orphanet J Rare Dis. 2020 Oct 15;15(1):289. doi: 10.1186/s13023-020-01570-x.
- Busse PJ, Christiansen SC, Riedl MA, Banerji A, Bernstein JA, Castaldo AJ, Craig T, Davis-Lorton M, Frank MM, Li HH, Lumry WR, Zuraw BL. US HAEA Medical Advisory Board 2020 Guidelines for the Management of Hereditary Angioedema. J Allergy Clin Immunol Pract. 2021 Jan;9(1):132-150.e3. doi: 10.1016/j.jaip.2020.08.046. Epub 2020 Sep 6.
- Cichon S, Martin L, Hennies HC, Muller F, Van Driessche K, Karpushova A, Stevens W, Colombo R, Renne T, Drouet C, Bork K, Nothen MM. Increased activity of coagulation factor XII (Hageman factor) causes hereditary angioedema type III. Am J Hum Genet. 2006 Dec;79(6):1098-104. doi: 10.1086/509899. Epub 2006 Oct 18.
- Dewald G, Bork K. Missense mutations in the coagulation factor XII (Hageman factor) gene in hereditary angioedema with normal C1 inhibitor. Biochem Biophys Res Commun. 2006 May 19;343(4):1286-9. doi: 10.1016/j.bbrc.2006.03.092.
- Lombardi AM, Bortoletto E, Scarparo P, Scapin M, Santarossa L, Girolami A. Genetic study in patients with factor XII deficiency: a report of three new mutations exon 13 (Q501STOP), exon 14 (P547L) and -13C>T promoter region in three compound heterozygotes. Blood Coagul Fibrinolysis. 2008 Oct;19(7):639-43. doi: 10.1097/MBC.0b013e32830d8629.
- Martin L, Raison-Peyron N, Nothen MM, Cichon S, Drouet C. Hereditary angioedema with normal C1 inhibitor gene in a family with affected women and men is associated with the p.Thr328Lys mutation in the F12 gene. J Allergy Clin Immunol. 2007 Oct;120(4):975-7. doi: 10.1016/j.jaci.2007.07.002. Epub 2007 Sep 7. No abstract available.
- Renne T, Gailani D. Role of Factor XII in hemostasis and thrombosis: clinical implications. Expert Rev Cardiovasc Ther. 2007 Jul;5(4):733-41. doi: 10.1586/14779072.5.4.733.
- Schmaier AH. The elusive physiologic role of Factor XII. J Clin Invest. 2008 Sep;118(9):3006-9. doi: 10.1172/JCI36617.
Condividi i tuoi pensieri o esperienze con gli altri nel nostro comunità di pazienti.
Iscriviti alla newsletter di Patient
La tua dose settimanale di consigli sulla salute chiari e affidabili - scritti per aiutarti a sentirti informato, sicuro e in controllo.
Abbonandoti accetti i nostri Informativa sulla Privacy. Puoi annullare l'iscrizione in qualsiasi momento. Non vendiamo mai i tuoi dati.

